2019 USCAP Meeting

2019 USCAP Meeting: PANCREATOBILIARY PATHOLOGY COMPANION SOCIETY PROGRAM

Thank you for attending our companion meeting at USCAP 2019! PDF versions of the presentations can now be downloaded from the links below.


Pancreatobiliary Pathology Society Companion Meeting USCAP 2019

Date:  March 16, 2019
National Harbor Washington DC

Challenging Topics in Pancreatic Neoplasia

Moderators:

  • Giuseppe Zamboni, University of Verona
  • Aatur D. Singhi, University of Pittsburgh Medical Center

Part I: Non-ductal Neoplasms of the Pancreas

  • Laura Wood, Johns Hopkins Hospital:

Pancreatic Neoplasms with Acinar Differentiation

  • Laura Tang, Memorial Sloan Kettering Cancer Center:

Pancreatic Neuroendocrine Neoplasm – Landscape and Horizon

  • Stephano La Rosa, Lausanne University Hospital:

Pancreatic solid pseudopapillary neoplasm – Key Histopathologic and Genetic Features

Part II: Neo-adjuvant Therapy in Pancreatic Ductal Adenocarcinoma

  • Huamin Wang, University of Texas MD Anderson Cancer Center:

Pathologic Evaluation of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications


USCAP 2019 PBPS Abstract Award Winner!

The winner of the USCAP 2019 PANCREATOBILIARY PATHOLOGY SOCIETY ABSTRACT AWARD WINNER is Dr. Prashant Bavi for his abstract titled
“Screening of NTRK fusions in pancreatic ductal adenocarcinomas by immunohistochemistry and comparison with NGS”
Congratulations Dr. Bavi!

USCAP2019 PBPS Abstract Winner Dr.Bavi with Dr.Basturk
USCAP2019 PBPS Abstract Winner Dr.Bavi with Dr.Basturk

Message from the President

Dear Pancreatobiliary Pathology Society Members,

It’s March, which means the 2019 annual USCAP meeting is upon us! Please join us on Saturday March 16th for our Companion Society Meeting: “Challenging Topics in Pancreatic Neoplasia: I: An Update on Non-ductal Neoplasms and II: Approach to Neo-adjuvant Treated Ductal Adenocarcinoma.” Our Education Committee has created an informative two-part session that will first cover non-ductal neoplasms of the pancreas followed by the pathologic evaluation of treated pancreatic cancer that will include an update about our Neo-adjuvant Therapy Working Group. The Education Committee has also been busy reviewing the 15 abstracts they received for the Pancreatobiliary Pathology Society Abstract Award, and the winner will be announced at our annual Business Meeting, which will immediately follow the Companion Society session from 9:45 pm – 10:00 pm. For those who are unable to attend, please check our website after the meeting.

Our society has been productive over the past several months in other areas as well. The next case of the quarter will soon be released – keep an eye out for it on our website! Our bimonthly journal watch nicely highlights pertinent publications involving the pancreatobiliary tract. Both of these activities are now perks of membership. If you are not an active member, please join or renew your membership online! If you are a new member, welcome! In addition to the Neo-adjuvant Therapy Working Group, we have two other active Working Groups: The Grossing Working Group is in the process of writing a manuscript and the Cytology Working Group has been formed and is gathering data.

Our society would not be a success if it were not for the tireless efforts of our members. I would like to recognize the following members who have been making an impact in our society: Olca Basturk, who was instrumental in organizing this year’s companion session; Serdar Balci for publishing the bimonthly journal watch; Jiaqi Shi and Michelle Reid for contributing the cases of the quarter; Mabel Ko for managing our website; and the members of the Executive Committee, Grace Kim, David Klimstra, David Lewin, Volkan Adsay and Olca, for keeping everything on track and in order.

I am proud to be part of this international organization that strives to improve the clinical practice of pancreatobiliary pathology by providing a comfortable environment of team work and cooperation. An organization from which will sprout future leaders in the field of pancreatobiliary pathology.

– Alyssa M. Krasinskas, MD


2019 USCAP Meeting

Date:  March 16, 2019
Time: 7 pm-10 pm

National Harbor Washington DC

Symposium Title: Challenging Topics in Pancreatic Neoplasia I: An Update on Non-ductal Neoplasms and II: Approach to Neo-adjuvant Treated Ductal Adenocarcinoma
Moderators: Giuseppe Zamboni, University of Verona and Aatur D. Singhi, University of Pittsburgh Medical Center

Part I: Non-ductal Neoplasms of the Pancreas

Laura Wood, Johns Hopkins Hospital: Pancreatic Neoplasms with Acinar Differentiation

Laura Tang, Memorial Sloan Kettering Cancer Center: Pancreatic Neuroendocrine Neoplasm – Landscape and Horizon

Stephano La Rosa, Lausanne University Hospital: Pancreatic solid pseudopapillary neoplasm – Key Histopathologic and Genetic Features

Part II: Neo-adjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Huamin Wang, University of Texas MD Anderson Cancer Center: Pathologic Evaluation of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications

Pancreatobiliary Pathology Society Business Meeting 9:45 pm- 10:00 pm